8
Oct
2024

Recordati SpA

Exhibitor at CPHI Milan 2024 stand 10C9, Finished Dosage Formulations
About Us

Recordati is an international pharmaceutical group listed on the Italian Stock Exchange uniquely structured to bring treatment across specialty and primary care, consumer healthcare, and rare diseases Established in 1926, Recordati operates in approximately 150 countries across EMEA, Americas and APAC regions. For more information, visit www.recordati.com.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 10C9, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • CYSTEAMINE BITRARTRATE

    Product CYSTEAMINE BITRARTRATE

    Recordati S.p.A provides a wide range of active pharmaceutical ingridients which includes Cysteamine Bitrartrate.  Contact us for more information.
  • Acyclovir

    Product Acyclovir

    Recordati S.p.A provides a wide range of active pharmaceutical ingridients which includes acyclovir. It belongs to antiviral category. Contact us for more information.
  • Benidipine HCl

    Product Benidipine HCl

    Recordati S.p.A provides a wide range of active pharmaceutical ingridients which includes benidipine HCl. It belongs to antihypertensive category. Contact us for more information.
  • Dimenhydrinate

    Product Dimenhydrinate

    Recordati S.p.A provides a wide range of active pharmaceutical ingridients which includes dimenhydrinate. It belongs to antiemetic category. Contact us for more information.
  • Diphenhydramine citrate

    Product Diphenhydramine citrate

    Recordati S.p.A provides a wide range of active pharmaceutical ingridients which includes diphenhydramine citrate. It belongs to antihistaminic category. Contact us for more information.